Fri, May 22, 2020

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Increased Target to $15 on, May 22nd, 2020

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Increased Target from $13 to $15 on, May 22nd, 2020.

Raghuram has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $36 on, Monday, February 10th, 2020


Similar Stocks and Investing Publications